title: Activation of ERα is necessary for estradiol's anorexigenic effect in female rats.
abstract: While there is considerable evidence that the ovarian hormone estradiol reduces food intake in female rats, it is unclear which estrogen receptor (ER) subtype, ERα or ERβ, mediates this effect. While several studies have demonstrated that activation of ERα, but not ERβ, is sufficient to reduce food intake in ovariectomized (OVX) rats, there are limited data regarding which receptor subtype is necessary. Here we used the selective ERα and ERß antagonists, MPrP and PHTPP, respectively, to investigate this question. We found that antagonism of ERα, but not ERβ, prevented the decrease in food intake following acute administration of estradiol in OVX rats. In addition, antagonism of ERα prevented the estrous-related, phasic reduction in food intake that occurs in response to the rise in circulating levels of estradiol in cycling rats. We conclude that activation of ERα is necessary for the anorexigenic effects of exogenous and endogenous estradiol in female rats.
authors.affiliation: Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, USA.
authors.forename: Jessica
authors.initials: J
authors.lastname: Santollo
authors.forename: Benita S
authors.initials: BS
authors.lastname: Katzenellenbogen
authors.forename: John A
authors.initials: JA
authors.lastname: Katzenellenbogen
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Eckel
mesh_terms: D000818:Animals; D000855:Anorexia / Q000139:chemically induced* / Q000378:metabolism; D001067:Appetite Depressants / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004435:Eating / Q000187:drug effects / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology* / Q000502:physiology; D047628:Estrogen Receptor alpha / Q000819:agonists* / Q000378:metabolism / Q000502:physiology; D005260:Female; D010052:Ovariectomy; D010880:Piperidines / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology
chemical_list: C524478:1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole; C556295:4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol; D001067:Appetite Depressants; D047628:Estrogen Receptor alpha; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; D020845:Selective Estrogen Receptor Modulators; D004958:Estradiol
references.citation: Brain Res. 1989 Jul 10;491(2):266-73
references.pmid: 2765887
references.citation: Proc Soc Exp Biol Med. 1998 Jan;217(1):45-52
references.pmid: 9421206
references.citation: Endocrinology. 2009 Feb;150(2):795-802
references.pmid: 18832099
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2501-6
references.pmid: 17284595
references.citation: Endocrinology. 2008 Sep;149(9):4658-68
references.pmid: 18511507
references.citation: Gen Comp Endocrinol. 2010 May 1;166(3):520-8
references.pmid: 20067798
references.citation: Physiol Behav. 2000 Aug-Sep;70(3-4):397-405
references.pmid: 11006440
references.citation: Physiol Behav. 1976 Aug;17(2):201-8
references.pmid: 1033580
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Dec;293(6):R2194-201
references.pmid: 17942491
references.citation: Endocrinology. 2001 Nov;142(11):4751-7
references.pmid: 11606440
references.citation: Physiol Behav. 2006 Jan 30;87(1):39-44
references.pmid: 16181647
references.citation: Am J Physiol. 1993 Jun;264(6 Pt 2):R1219-23
references.pmid: 8322977
references.citation: Physiol Behav. 2009 May 25;97(2):193-8
references.pmid: 19254732
references.citation: Horm Metab Res. 2002 Nov-Dec;34(11-12):758-63
references.pmid: 12660895
references.citation: Mol Reprod Dev. 2006 Aug;73(8):1034-44
references.pmid: 16688783
references.citation: J Med Chem. 2004 Nov 18;47(24):5872-93
references.pmid: 15537344
references.citation: Fed Proc. 1987 Apr;46(5):1870-4
references.pmid: 3556610
references.citation: Am J Physiol. 1993 Dec;265(6 Pt 2):R1392-8
references.pmid: 8285282
references.citation: Life Sci. 2009 Feb 27;84(9-10):282-9
references.pmid: 19146862
references.citation: Endocrinology. 2002 Mar;143(3):941-7
references.pmid: 11861516
references.citation: Horm Behav. 2002 Dec;42(4):461-71
references.pmid: 12488112
references.citation: Mol Cell Endocrinol. 2003 Aug 29;206(1-2):13-22
references.pmid: 12943986
references.citation: Horm Behav. 1979 Oct;13(2):97-112
references.pmid: 399606
references.citation: Int J Obes Relat Metab Disord. 2002 Aug;26(8):1103-9
references.pmid: 12119576
references.citation: Neuropsychopharmacology. 2005 Sep;30(9):1598-609
references.pmid: 15798780
references.citation: Brain Res. 2009 May 1;1268:88-96
references.pmid: 19281799
references.citation: J Mol Endocrinol. 2008 Oct;41(4):205-17
references.pmid: 18632874
references.citation: Bioorg Med Chem Lett. 2009 Jan 1;19(1):108-10
references.pmid: 19014882
references.citation: Endocrinology. 2005 Apr;146(4):1650-73
references.pmid: 15618360
references.citation: Endocrinology. 1998 Dec;139(12):5070-81
references.pmid: 9832446
references.citation: Anim Behav. 1973 Nov;21(4):772-80
references.pmid: 4798198
references.citation: Horm Behav. 2001 Mar;39(2):121-30
references.pmid: 11243740
references.citation: Physiol Behav. 1979 Mar;22(3):583-93
references.pmid: 379889